Alfano Optical Tomography LLC is a technology licensing company that was established to further develop and expand applications for the technology covered U.S. Patent No. 6,208,886 “Non-Linear Optical Tomography of Turbid Media.” This patent covers advanced technology in the area of three-dimensional imaging of living human tissue, a critical factor in successful disease detection, diagnosis and treatment. The invention has multiple elements that work together to create this 3D image. A stage supports the tissue; a laser illuminates the tissue; light emerging from the tissue is comprised of fundamental light, harmonic wave light and fluorescence; a filter selectively passes at least one of the harmonic wave lights and fluorescence; there are detectors for each of the harmonic wave lights and fluorescence; and a mechanism moves the laser on x, y and z axes.
The invention covered by this patent has numerous applications in medical disease detection, diagnosis and treatment because it enables the production of high-resolution neuronal images of the cortex of a living human brain. Alfano Optical Tomography was established to further develop the technology covered by the ‘886 patent, expand the use of this patented technology, and – ultimately – commercialize and monetize the Alfano intellectual property, primarily through licensing.
Alfano Optical Tomography LLC is a subsidiary of General Patent Corporation, a leading patent monetization firm. General Patent is the managing member of Alfano Optical Tomography and is the exclusive licensing agent for the company’s patents.